Covid-19 Vaccine Trials
Covid-19 vaccine trials at our vaccine hub, Bethnal Green Library
During the pandemic, our researchers have run trials looking for Covid-19 treatments, and we've also been involved in trials testing new vaccines against the virus. This includes the Janssen (Johnson & Johnson) ENSEMBLE-2 vaccine candidate clinical trial. This phase III trial, which is in the early stages and is being carried out at the bespoke vaccines trial centre at the Bethnal Green Library, is showing promising early results. So far, over 600 participants have been enrolled in the study at the Barts Health site, making it one of the top recruiting sites for the study globally. It is hoped this study, which is examining the effects of a 2-dose vaccine regimen, will result in another vaccine to be licensed for use in the UK.
Read through some of the most commonly asked questions about COVID-19 vaccine trials
Vaccines for all: a community conversation about Covid-19 vaccines research
In December 2020, we held a community conversation with faith and community leaders, healthcare professionals and clinical academics. The session included a series of short talks to discuss Covid-19 vaccines research and why it's important that people from all ethnicities, ages and health groups take part. If you missed it, you can watch the recording here.
Barts Health research news
Barts Health Covid-19 Research Advisory Group
The Barts Health COVID-19 Research Patient and Public Inolvement and Engagement (PPIE) Advisory Group was established in response to the COVID-19 pandemic, primarily to provide a forum for those who are interested in working together to promote COVID-19 research and related patient and public involvement/engagement and ceased activity December 2020.
The lay advisory group consisted of local patient representatives, Barts Health Patient Research Champions and staff from the Barts Health Research Engagement and Diffusion team. The group met monthly during 2020 to discuss the development of projects in raising awareness of COVID-19 research and the related patient and public involvement, as well as reviewing documents, helping us expand our networks and circulating information etc.